New York Presbyterian — New York, New York

New York Presbyterian is a clinical research site located in New York, New York, United States 10032.

Crixeo Clinical Trials Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

New York Presbyterian has participated in 5 clinical trials.

Therapeutic areas: Structural Cardiac Defects, Acute Myeloid Leukemia, Paroxysmal Atrial Fibrillation.

Sponsors: RealView Imaging, Cephalon, Biosense Webster, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Presbyterian?

New York Presbyterian has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Presbyterian conducted?

New York Presbyterian has 5 clinical trials on record. Their work covers Structural Cardiac Defects, Acute Myeloid Leukemia, Paroxysmal Atrial Fibrillation.

Is New York Presbyterian accredited by Crixeo Clinical Trials?

New York Presbyterian has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Presbyterian?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.